• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[感染人类免疫缺陷病毒的受试者体内的抗包膜和抗衣壳抗体]

[Anti-env and anti-gag antibodies in subjects infected with the human immunodeficiency virus].

作者信息

Sanz del Forcallo F J, García Delgado R, Ortiz Maslloréns F

出版信息

Rev Clin Esp. 1989 Dec;185(9):443-7.

PMID:2696006
Abstract

Antibodies to antigens codified by the env and gag genes of HIV were separately assayed for in the sera of 150 infected people. From a practical standpoint, enzyme immunoassay was a more convenient and reliable technique than Western blot. Anti-env was positive in 100% and anti-gag in 70% of the cases. A positive anti-env test was confirmatory of serological diagnosis, but lacked any prognostic value. A higher frequency of negative results for anti-gag antibody was significantly associated with the presence of more severe clinical manifestations, more profound impairment of lymphocyte subpopulations (especially CD4 cells), and the finding of HIV antigens in blood. The absence of anti-gag antibodies, which seem to behave as protective, is an unfavorable feature in the clinical and immunological evaluation of patients.

摘要

对150名感染者的血清分别检测了针对HIV env和gag基因编码抗原的抗体。从实际角度来看,酶免疫测定法是一种比蛋白质印迹法更便捷、更可靠的技术。100%的病例抗env呈阳性,70%的病例抗gag呈阳性。抗env检测呈阳性可确诊血清学诊断,但缺乏任何预后价值。抗gag抗体阴性结果的较高频率与更严重的临床表现、淋巴细胞亚群(尤其是CD4细胞)更严重的损伤以及血液中HIV抗原的发现显著相关。抗gag抗体似乎具有保护作用,其缺失在患者的临床和免疫学评估中是一个不利特征。

相似文献

1
[Anti-env and anti-gag antibodies in subjects infected with the human immunodeficiency virus].[感染人类免疫缺陷病毒的受试者体内的抗包膜和抗衣壳抗体]
Rev Clin Esp. 1989 Dec;185(9):443-7.
2
Evaluation of a new dot blot assay for confirmation of human immunodeficiency virus type 1 and 2 infections using recombinant p24, gp41, gp120 and gp36 antigens.使用重组p24、gp41、gp120和gp36抗原评估一种用于确认1型和2型人类免疫缺陷病毒感染的新型斑点印迹检测法。
Saudi Med J. 2006 Jan;27(1):31-6.
3
[HIV infection and T-lymphocyte behavior: results of a study in Palermo].[HIV感染与T淋巴细胞行为:巴勒莫的一项研究结果]
Ann Ig. 1989 Jan-Apr;1(1-2):45-50.
4
Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.携带载体的Gag和Env而非Tat在Mamu - A*01阴性恒河猴中对猿猴 - 人类免疫缺陷病毒89.6P攻击显示出有效性。
J Virol. 2005 Oct;79(19):12321-31. doi: 10.1128/JVI.79.19.12321-12331.2005.
5
Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.利用嵌合gag-env病毒样颗粒开发艾滋病毒/艾滋病疫苗。
Biol Chem. 1999 Mar;380(3):353-64. doi: 10.1515/BC.1999.047.
6
Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.编码猿猴免疫缺陷病毒gag基因和人类免疫缺陷病毒env基因的5型/35型嵌合腺病毒载体可使猴子对猿猴/人类免疫缺陷病毒产生保护性免疫。
Virology. 2007 Oct 25;367(2):390-7. doi: 10.1016/j.virol.2007.06.012. Epub 2007 Jul 12.
7
Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.在恒河猴SHIV模型中,使用重组env - gag - pol痘苗病毒安卡拉(MVA)疫苗策略并辅以或不辅以寡聚Env蛋白加强免疫的比较。
Virology. 2002 Mar 15;294(2):270-81. doi: 10.1006/viro.2001.1345.
8
Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.来自感染HIV-1 C亚型的印度患者的细胞毒性T淋巴细胞(CTL)识别来自HIV-1 Gag和Nef保守免疫显性区域的CTL表位。
J Infect Dis. 2005 Sep 1;192(5):749-59. doi: 10.1086/432547. Epub 2005 Jul 27.
9
Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.用细胞内抗HIV-1 p17抗体基因转导的原代人T细胞中HIV-1复制的抑制作用
J Gene Med. 2003 Mar;5(3):182-9. doi: 10.1002/jgm.336.
10
Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.对致病性单核细胞增生李斯特菌的既有免疫力并不妨碍新型重组单核细胞增生李斯特菌疫苗诱导针对猫免疫缺陷病毒的免疫反应。
Vaccine. 2005 Feb 10;23(12):1479-90. doi: 10.1016/j.vaccine.2004.09.033.